294 related articles for article (PubMed ID: 22936807)
1. Novel IL27p28/IL12p40 cytokine suppressed experimental autoimmune uveitis by inhibiting autoreactive Th1/Th17 cells and promoting expansion of regulatory T cells.
Wang RX; Yu CR; Mahdi RM; Egwuagu CE
J Biol Chem; 2012 Oct; 287(43):36012-21. PubMed ID: 22936807
[TBL] [Abstract][Full Text] [Related]
2. STAT3 activates miR-155 in Th17 cells and acts in concert to promote experimental autoimmune uveitis.
Escobar T; Yu CR; Muljo SA; Egwuagu CE
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4017-25. PubMed ID: 23674757
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of IL-27 Signaling Exacerbates Experimental Autoimmune Uveitis with Elevated Uveitogenic Th1 and Th17 Responses.
Wu S; Ma R; Zhong Y; Chen Z; Zhou H; Zhou M; Chong W; Chen J
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299138
[TBL] [Abstract][Full Text] [Related]
4. AS101 ameliorates experimental autoimmune uveitis by regulating Th1 and Th17 responses and inducing Treg cells.
Bing SJ; Shemesh I; Chong WP; Horai R; Jittayasothorn Y; Silver PB; Sredni B; Caspi RR
J Autoimmun; 2019 Jun; 100():52-61. PubMed ID: 30853312
[TBL] [Abstract][Full Text] [Related]
5. IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses.
Chong WP; Horai R; Mattapallil MJ; Silver PB; Chen J; Zhou R; Sergeev Y; Villasmil R; Chan CC; Caspi RR
J Autoimmun; 2014 May; 50():12-22. PubMed ID: 24021664
[TBL] [Abstract][Full Text] [Related]
6. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
[TBL] [Abstract][Full Text] [Related]
7. SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis (EAU).
Vistica BP; Shi G; Nugent L; Tan C; Altman A; Gery I
Mol Vis; 2012; 18():1858-64. PubMed ID: 22815639
[TBL] [Abstract][Full Text] [Related]
8. STAT3-Specific Single Domain Nanobody Inhibits Expansion of Pathogenic Th17 Responses and Suppresses Uveitis in Mice.
Mbanefo EC; Yan M; Kang M; Alhakeem SA; Jittayasothorn Y; Yu CR; Parihar A; Singh S; Egwuagu CE
Front Immunol; 2021; 12():724609. PubMed ID: 34603297
[TBL] [Abstract][Full Text] [Related]
9. Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases.
Liu X; Lee YS; Yu CR; Egwuagu CE
J Immunol; 2008 May; 180(9):6070-6. PubMed ID: 18424728
[TBL] [Abstract][Full Text] [Related]
10. The role of Th17-associated cytokines in the pathogenesis of experimental autoimmune uveitis (EAU).
Sun D; Liang D; Kaplan HJ; Shao H
Cytokine; 2015 Jul; 74(1):76-80. PubMed ID: 25742774
[TBL] [Abstract][Full Text] [Related]
11. STAT3 deficiency in B cells exacerbates uveitis by promoting expansion of pathogenic lymphocytes and suppressing regulatory B cells (Bregs) and Tregs.
Oladipupo FO; Yu CR; Olumuyide E; Jittaysothorn Y; Choi JK; Egwuagu CE
Sci Rep; 2020 Oct; 10(1):16188. PubMed ID: 33004854
[TBL] [Abstract][Full Text] [Related]
12. An A2B Adenosine Receptor Agonist Promotes Th17 Autoimmune Responses in Experimental Autoimmune Uveitis (EAU) via Dendritic Cell Activation.
Chen M; Liang D; Zuo A; Shao H; Kaplan HJ; Sun D
PLoS One; 2015; 10(7):e0132348. PubMed ID: 26147733
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic Function of Herpesvirus Entry Mediator in Experimental Autoimmune Uveitis by Induction of Th1- and Th17-Type T Cell Responses.
Sakoda Y; Nagai T; Murata S; Mizuno Y; Kurosawa H; Shoda H; Morishige N; Yanai R; Sonoda KH; Tamada K
J Immunol; 2016 Apr; 196(7):2947-54. PubMed ID: 26912321
[TBL] [Abstract][Full Text] [Related]
14. EBI3 is pivotal for the initiation of experimental autoimmune uveitis.
Takeda A; Hasegawa E; Fukuhara T; Hirakawa S; Yamada H; Yang Y; Yoshimura T; Hisatomi T; Oshima Y; Yoshida H; Sonoda KH; Ishibashi T
Exp Eye Res; 2014 Aug; 125():107-13. PubMed ID: 24929202
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic targeting of STAT3 (signal transducers and activators of transcription 3) pathway inhibits experimental autoimmune uveitis.
Yu CR; Lee YS; Mahdi RM; Surendran N; Egwuagu CE
PLoS One; 2012; 7(1):e29742. PubMed ID: 22238646
[TBL] [Abstract][Full Text] [Related]
16. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS
Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009
[TBL] [Abstract][Full Text] [Related]
17. IL-12p40 Homodimer Ameliorates Experimental Autoimmune Arthritis.
Lee SY; Jung YO; Kim DJ; Kang CM; Moon YM; Heo YJ; Oh HJ; Park SJ; Yang SH; Kwok SK; Ju JH; Park SH; Sung YC; Kim HY; Cho ML
J Immunol; 2015 Oct; 195(7):3001-10. PubMed ID: 26324771
[TBL] [Abstract][Full Text] [Related]
18. IL-22-induced regulatory CD11b+ APCs suppress experimental autoimmune uveitis.
Ke Y; Sun D; Jiang G; Kaplan HJ; Shao H
J Immunol; 2011 Sep; 187(5):2130-9. PubMed ID: 21795593
[TBL] [Abstract][Full Text] [Related]
19. SOCS3 deletion in T lymphocytes suppresses development of chronic ocular inflammation via upregulation of CTLA-4 and expansion of regulatory T cells.
Yu CR; Kim SH; Mahdi RM; Egwuagu CE
J Immunol; 2013 Nov; 191(10):5036-43. PubMed ID: 24101549
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of IFN-β on IL-12, IL-23, and IL-10 expression in TLR-stimulated dendritic cells.
Yen JH; Kong W; Hooper KM; Emig F; Rahbari KM; Kuo PC; Scofield BA; Ganea D
J Leukoc Biol; 2015 Nov; 98(5):689-702. PubMed ID: 26059829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
